Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cancer Biomarkers Market, by Profiling Technologies
1.4.2 North America Cancer Biomarkers Market, by Application
1.4.3 North America Cancer Biomarkers Market, by Type
1.4.4 North America Cancer Biomarkers Market, by Cancer Type
1.4.5 North America Cancer Biomarkers Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Cancer Biomarkers Market
Chapter 4. North America Cancer Biomarkers Market by Profiling Technologies
4.1 North America Omics Technologies Market by Country
4.2 North America Imaging Technologies Market by Country
4.3 North America Immunoassay Market by Country
4.4 North America Bioinformatics Market by Country
4.5 North America Cytogenetics Market by Country
Chapter 5. North America Cancer Biomarkers Market by Application
5.1 North America Diagnostics Market by Country
5.2 North America Research & Development Market by Country
5.3 North America Prognostics Market by Country
5.4 North America Risk Assessment Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Cancer Biomarkers Market by Type
6.1 North America Protein Market by Country
6.2 North America Genetic Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Cancer Biomarkers Market by Cancer Type
7.1 North America Breast Cancer Market by Country
7.2 North America Lung Cancer Market by Country
7.3 North America Colorectal Cancer Market by Country
7.4 North America Thyroid Cancer Market by Country
7.5 North America Melanoma & Leukemia Market by Country
7.6 North America Kidney & Bladder Cancer Market by Country
7.7 North America Non-Hodgkin's Lymphoma Market by Country
7.8 North America Prostate Cancer Market by Country
7.9 North America Others Market by Country
Chapter 8. North America Cancer Biomarkers Market by Country
8.1 US Cancer Biomarkers Market
8.1.1 US Cancer Biomarkers Market by Profiling Technologies
8.1.2 US Cancer Biomarkers Market by Application
8.1.3 US Cancer Biomarkers Market by Type
8.1.4 US Cancer Biomarkers Market by Cancer Type
8.2 Canada Cancer Biomarkers Market
8.2.1 Canada Cancer Biomarkers Market by Profiling Technologies
8.2.2 Canada Cancer Biomarkers Market by Application
8.2.3 Canada Cancer Biomarkers Market by Type
8.2.4 Canada Cancer Biomarkers Market by Cancer Type
8.3 Mexico Cancer Biomarkers Market
8.3.1 Mexico Cancer Biomarkers Market by Profiling Technologies
8.3.2 Mexico Cancer Biomarkers Market by Application
8.3.3 Mexico Cancer Biomarkers Market by Type
8.3.4 Mexico Cancer Biomarkers Market by Cancer Type
8.4 Rest of North America Cancer Biomarkers Market
8.4.1 Rest of North America Cancer Biomarkers Market by Profiling Technologies
8.4.2 Rest of North America Cancer Biomarkers Market by Application
8.4.3 Rest of North America Cancer Biomarkers Market by Type
8.4.4 Rest of North America Cancer Biomarkers Market by Cancer Type
Chapter 9. Company Profiles
9.1 BioMérieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.6 SWOT Analysis
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Qiagen N.V.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Product Launches and Product Expansions:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Merck & Co., Inc. (Merck Millipore)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
Unique Offerings 
